Skip to main content
Raven Country

Baltimore Ravens TE Mark Andrews Reveals New Partnership With Biotech Company to Raise Awareness

The Baltimore Ravens franchise record holder continues to be an advocate and inspiration for those who also live with diabetes and the other conditions that can manifest as a result.
Nov 25, 2024; Inglewood, California, USA; Baltimore Ravens tight end Mark Andrews (89) is interviewed by NFL Network reporter Bridget Condon after the game against the Los Angeles Chargers at SoFi Stadium. Mandatory Credit: Kirby Lee-Imagn Images
Nov 25, 2024; Inglewood, California, USA; Baltimore Ravens tight end Mark Andrews (89) is interviewed by NFL Network reporter Bridget Condon after the game against the Los Angeles Chargers at SoFi Stadium. Mandatory Credit: Kirby Lee-Imagn Images | Kirby Lee-Imagn Images

In this story:

After being diagnosed at nine years old, Baltimore Ravens star tight end Mark Andrews has been living with type 1 diabetes for two-thirds of his life and has spent his nearly decade-long career in the NFL advocating for those who also battle with autoimmune disease and other conditions that can stem from it.

In a recent interview with Ravens On SI, the three-time Pro Bowler announced a partnership with the renowned biotechnology company, Genentech, to raise awareness among people with diabetic macular edema (DME), a complication of diabetic retinopathy. It causes fluid to build up in the macula—the part of the retina responsible for sharp, central vision. The cause of the condition is high blood sugar weakening and leaking retinal blood vessels, which leads to blurry vision, distorted shapes, and potential vision loss.

“I think something that is super important is your eyesight, obviously, being a football player, being able to have great vision is something super important,” Andrews said. “(As a person) living with diabetes, another thing, you know, to bring awareness to is to get your vision screenings yearly.”

DME is a very common eye condition among people with diabetes, and companies like Genentech are among the industry leaders in trying to develop treatments to combat these types of autoimmune diseases.

“It's really cool, and I think it's, it's amazing that there's companies out there to help,” Andrews said. “DME is something that is very serious, and again, that's the main thing, is just bringing awareness for people with diabetes to go out there, get your vision checked, talk to your doctor.”

Using spotlight to inspire others

Baltimore Ravens tight end Mark Andrews (89) before the game against the Cincinnati Bengals at M&T Bank Stadium.
Oct 9, 2022; Baltimore, Maryland, USA; Baltimore Ravens tight end Mark Andrews (89) before the game against the Cincinnati Bengals at M&T Bank Stadium. Mandatory Credit: Tommy Gilligan-Imagn Images | Tommy Gilligan-Imagn Images


As not only a professional athlete but one of the best tight ends in the league and the holder of several Ravens franchise records, Andrews loves using his platform to be an advocate for people with diabetes and other conditions that can stem from it because of the wide and lasting impact the involvement of someone of his status can have.


“It's incredibly important,” Andrews said. “I think for me, at a young age, being diagnosed with diabetes, and then having a platform of playing sports, and people seeing that, and seeing me, I took it very personally to live my life, and to show other people that they can do anything they want in life.

The 30-year-old shared that living with diabetes is a full-time job and is by no means easy, so he takes tremendous pride in showing those who do share in his plight that their dreams can still come to fruition.


“For me, just to show people that they're not alone in this fight, there's other people like them out there, and that, even though you have diabetes, don't let it stop you from doing anything more,” Andrews said.

Add us as a preferred source on Google

Loading recommendations... Please wait while we load personalized content recommendations


Published
Josh Reed
JOSH REED

Josh is a writer for Baltimore Ravens On SI focusing primarily on original content and reporting. He provides analysis, breakdowns, profiles, and reports on important news and transactions from and about the Ravens. His professional resume as a sports reporter includes covering local events, teams, and athletes in his hometown of Anchorage, Alaska for Anchorage Daily News. His coverage on the Ravens and other NFL teams has been featured on Heavy.com/sports, Maryland Sports Blog and most recently Baltimore Beatdown from 2021 until 2025.